Sang-Ho Ma

Title: Innovations of Sang-Ho Ma

Introduction

Sang-Ho Ma is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target various diseases. With a total of 2 patents, his work has the potential to impact the treatment of serious health conditions.

Latest Patents

Sang-Ho Ma's latest patents include innovative compounds that have shown promise in medical applications. One of his notable inventions is a compound having a 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof. This compound exhibits inhibitory activity against glucosylceramide synthase (GCS), making it useful for preventing or treating diseases such as Gaucher disease, Fabry disease, Tay-Sachs disease, and Parkinson's disease. Another significant patent involves a compound of a reverse-turn mimetic, which has pyrazino-triazinone as a basic framework. This invention is aimed at treating diseases like cancer, particularly acute myeloid leukemia.

Career Highlights

Throughout his career, Sang-Ho Ma has worked with prominent companies in the pharmaceutical industry. He has been associated with Yuhan Corporation and The Green Cross Corporation, where he has contributed to various research and development projects. His expertise in medicinal chemistry has been instrumental in advancing therapeutic solutions.

Collaborations

Sang-Ho Ma has collaborated with several professionals in his field, including Dong-Hoon Kim and Jae-Eun Joo. These collaborations have fostered innovation and have led to the development of groundbreaking pharmaceutical compounds.

Conclusion

Sang-Ho Ma's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of critical diseases.